{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:39:24Z","timestamp":1791434364314,"version":"4.3.3"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>An increasing number of emergency departments (EDs) are initiating buprenorphine for opioid use disorder (OUD) and linking patients to ongoing community-based treatment, yet community-based clinician and staff perspectives regarding this practice have not been characterized.<\/jats:p><\/jats:sec>Objective<\/jats:title>To explore perspectives and experiences regarding ED-initiated buprenorphine among community-based clinicians and staff in geographically distinct regions.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This qualitative study reports findings from Project ED Health, a hybrid type 3 effectiveness-implementation study designed to evaluate the impact of implementation facilitation on ED-initiated buprenorphine with referral to ongoing medication treatment. Clinicians and staff from community-based treatment programs were identified by urban academic EDs as potential referral sites for ongoing OUD treatment in 4 cities across the US in a formative evaluation as having the capability to continue medication treatment. Focus groups were held from April 1, 2018, to January 11, 2019, to examine community OUD treatment clinician and staff perspectives on accepting patients who have received ED-initiated buprenorphine. Data were analyzed from August 2020 to August 2022.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Data collection and analysis were grounded in the Promoting Action on Research Implementation in Health Services (PARIHS) implementation science framework, focusing on domains including evidence, context, and facilitation.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 103 individuals (mean [SD] age, 45.3 [12.0] years; 76 female and 64 White) participated in 14 focus groups (groups ranged from 3-22 participants). Participants shared negative attitudes toward buprenorphine and variable attitudes toward ED-initiated buprenorphine. Prominent barriers included the community site treatment capacity and structure as well as payment and regulatory barriers. Perceived factors that could facilitate this model included additional substance use disorder training for ED staff, referrals and communication, greater inclusion of peer navigators, and addressing sociostructural marginalization that patients faced.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this study of community-based clinicians and staff positioned to deliver OUD treatment, participants reported many barriers to successful linkages for patients who received ED-initiated buprenorphine. Strategies to improve these linkages included educating communities and programs, modeling low-barrier philosophies, and using additional staff trained in addiction as resources to improve transitions from EDs to community partners.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.12718","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T16:29:42Z","timestamp":1683736182000},"page":"e2312718","source":"Crossref","is-referenced-by-count":7,"title":["Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department\u2013Initiated Buprenorphine Programs"],"prefix":"10.1001","volume":"6","author":[{"given":"Kimberly L.","family":"Sue","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Yale Program in Addiction Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Chawarski","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Curry","sequence":"additional","affiliation":[{"name":"Health Policy and Management, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"McNeil","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Yale Program in Addiction Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Edouard","family":"Coupet","sequence":"additional","affiliation":[{"name":"Yale Program in Addiction Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Friends Research Institute, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Wilder","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith I.","family":"Tsui","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington School of Medicine, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn F.","family":"Hawk","sequence":"additional","affiliation":[{"name":"Yale Program in Addiction Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"D\u2019Onofrio","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Yale Program in Addiction Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick G.","family":"O\u2019Connor","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Yale Program in Addiction Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fiellin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Yale Program in Addiction Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Jennifer","family":"Edelman","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Yale Program in Addiction Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,5,10]]},"reference":[{"issue":"2","key":"zoi230392r2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder.","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"26","key":"zoi230392r3","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMp1811988","article-title":"Emergency departments: a 24\/7\/365 option for combating the opioid crisis.","volume":"379","author":"D\u2019Onofrio","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"zoi230392r4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.15585\/mmwr.mm6709e1","article-title":"Vital signs: trends in emergency department visits for suspected opioid overdoses: United States, July 2016-September 2017.","volume":"67","author":"Vivolo-Kantor","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"zoi230392r5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.annemergmed.2018.11.032","article-title":"Managing opioid withdrawal in the emergency department with buprenorphine.","volume":"73","author":"Herring","year":"2019","journal-title":"Ann Emerg Med"},{"issue":"16","key":"zoi230392r6","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial.","volume":"313","author":"D\u2019Onofrio","year":"2015","journal-title":"JAMA"},{"issue":"11","key":"zoi230392r7","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1111\/add.v112.11","article-title":"Cost-effectiveness of emergency department-initiated treatment for opioid dependence.","volume":"112","author":"Busch","year":"2017","journal-title":"Addiction"},{"issue":"1","key":"zoi230392r8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00952990.2018.1546862","article-title":"Development of a cascade of care for responding to the opioid epidemic.","volume":"45","author":"Williams","year":"2019","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"zoi230392r9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/ADM.0000000000000555","article-title":"Defining low-threshold buprenorphine treatment.","volume":"14","author":"Jakubowski","year":"2020","journal-title":"J Addict Med"},{"issue":"6","key":"zoi230392r10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.5811\/westjem","article-title":"Beyond buprenorphine: models of follow-up care for opioid use disorder in the emergeny department.","volume":"21","author":"Martin","year":"2020","journal-title":"West J Emerg Med"},{"issue":"4","key":"zoi230392r11","doi-asserted-by":"publisher","first-page":"451","DOI":"10.5811\/westjem","article-title":"Implementing a novel statewide network to support emergency department-initiated buprenorphine treatment.","volume":"23","author":"Clemency","year":"2022","journal-title":"West J Emerg Med"},{"issue":"7","key":"zoi230392r12","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1080\/10826084.2021.1906280","article-title":"Linking MATTERS: barriers and facilitators to implementing emergency department-initiated buprenorphine-naloxone in patients with opioid use disorder and linkage to long-term care.","volume":"56","author":"Sokol","year":"2021","journal-title":"Subst Use Misuse"},{"issue":"5","key":"zoi230392r13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.annemergmed.2022.01.042","article-title":"Subsequent buprenorphine treatment following emergency physician buprenorphine prescription fills: a national assessment 2019 to 2020.","volume":"79","author":"Stein","year":"2022","journal-title":"Ann Emerg Med"},{"issue":"1","key":"zoi230392r14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13012-019-0891-5","article-title":"Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).","volume":"14","author":"D\u2019Onofrio","year":"2019","journal-title":"Implement Sci"},{"issue":"Suppl 2","key":"zoi230392r15","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/jgi.2006.21.issue-s2","article-title":"The role of formative evaluation in implementation research and the QUERI experience.","volume":"21 Suppl 2","author":"Stetler","year":"2006","journal-title":"J Gen Intern Med"},{"issue":"4","key":"zoi230392r16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.5439","article-title":"Implementation facilitation to promote emergency department\u2013initiated buprenorphine for opioid use disorder.","volume":"6","author":"D\u2019Onofrio","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"9","key":"zoi230392r17","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","article-title":"Standards for reporting qualitative research: a synthesis of recommendations.","volume":"89","author":"O\u2019Brien","year":"2014","journal-title":"Acad Med"},{"key":"zoi230392r18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1748-5908-6-99","article-title":"A guide for applying a revised version of the PARIHS framework for implementation.","volume":"6","author":"Stetler","year":"2011","journal-title":"Implement Sci"},{"issue":"3","key":"zoi230392r19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1136\/qshc.7.3.149","article-title":"Enabling the implementation of evidence based practice: a conceptual framework.","volume":"7","author":"Kitson","year":"1998","journal-title":"Qual Health Care"},{"issue":"4","key":"zoi230392r20","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1111\/hesr.2007.42.issue-4","article-title":"Qualitative data analysis for health services research: developing taxonomy, themes, and theory.","volume":"42","author":"Bradley","year":"2007","journal-title":"Health Serv Res"},{"issue":"1","key":"zoi230392r22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1525822X16639015","article-title":"How many focus groups are enough? Building an evidence base for nonprobability sample sizes.","volume":"29","author":"Guest","year":"2017","journal-title":"Field Methods"},{"key":"zoi230392r23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1748-5908-8-28","article-title":"The role of evidence, context, and facilitation in an implementation trial: implications for the development of the PARIHS framework.","volume":"8","author":"Rycroft-Malone","year":"2013","journal-title":"Implement Sci"},{"issue":"5","key":"zoi230392r25","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.annemergmed.2022.05.010","article-title":"Models for implementing emergency department-initiated buprenorphine with referral for ongoing medication treatment at emergency department discharge in diverse academic centers.","volume":"80","author":"Whiteside","year":"2022","journal-title":"Ann Emerg Med"},{"issue":"4","key":"zoi230392r26","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.annemergmed.2018.04.007","article-title":"Identification, management, and transition of care for patients with opioid use disorder in the emergency department.","volume":"72","author":"Duber","year":"2018","journal-title":"Ann Emerg Med"},{"issue":"5","key":"zoi230392r27","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.4996","article-title":"Overcoming barriers to prescribing buprenorphine in the emergency department.","volume":"3","author":"Kim","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"9","key":"zoi230392r28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-053207","article-title":"Facilitators of and barriers to buprenorphine initiation for people with opioid use disorder in the emergency department: protocol for a scoping review.","volume":"11","author":"Bozinoff","year":"2021","journal-title":"BMJ Open"},{"issue":"2","key":"zoi230392r29","doi-asserted-by":"publisher","DOI":"10.1002\/emp2.v2.2","article-title":"Improving transitions of care for patients initiated on buprenorphine for opioid use disorder from the emergency departments in King County, Washington.","volume":"2","author":"Fockele","year":"2021","journal-title":"J Am Coll Emerg Physicians Open"},{"issue":"4","key":"zoi230392r30","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/ADM.0000000000000943","article-title":"Barriers to engagement in opioid use disorder treatment after buprenorphine induction.","volume":"16","author":"Simpson","year":"2022","journal-title":"J Addict Med"},{"issue":"1","key":"zoi230392r31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/ADM.0000000000000810","article-title":"Peer recovery support services across the continuum: in community, hospital, corrections, and treatment and recovery agency settings: a narrative review.","volume":"16","author":"Stack","year":"2022","journal-title":"J Addict Med"},{"issue":"4","key":"zoi230392r32","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/00952990.2019.1605372","article-title":"The case for a medication first approach to the treatment of opioid use disorder.","volume":"45","author":"Winograd","year":"2019","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"1","key":"zoi230392r33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13722-019-0149-1","article-title":"Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco.","volume":"14","author":"Carter","year":"2019","journal-title":"Addict Sci Clin Pract"},{"issue":"1","key":"zoi230392r34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/08897077.2015.1062457","article-title":"Counselor training and attitudes toward pharmacotherapies for opioid use disorder.","volume":"37","author":"Aletraris","year":"2016","journal-title":"Subst Abus"},{"issue":"6","key":"zoi230392r35","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.annemergmed.2021.05.024","article-title":"Rapid adoption of low-threshold buprenorphine treatment at California emergency departments participating in the CA Bridge Program.","volume":"78","author":"Snyder","year":"2021","journal-title":"Ann Emerg Med"},{"issue":"3","key":"zoi230392r37","doi-asserted-by":"publisher","DOI":"10.1002\/emp2.v2.3","article-title":"Advancing emergency department-initiated buprenorphine.","volume":"2","author":"Huntley","year":"2021","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"zoi230392r21","volume-title":"Handbook for Team-Based Qualitative Research","author":"Guest","year":"2008"},{"key":"zoi230392r38","volume-title":"Thinking about Answers: The Application of Cognitive Processes to Survey Methodology","author":"Sudman","year":"1996"},{"key":"zoi230392r39","volume-title":"Qualitative Research & Evaluation Methods","author":"Patton","year":"2002"},{"key":"zoi230392r40","volume-title":"The Evaluator as Instrument. In: Effective Evaluation","author":"Guba","year":"1981"},{"key":"zoi230392r1","unstructured":"US Centers for Disease Control and Prevention. Death rate maps and graphs. June 2, 2022. Accessed December 12, 2022. https:\/\/www.cdc.gov\/drugoverdose\/deaths\/index.html"},{"key":"zoi230392r24","unstructured":"Substance Abuse and Mental Health Services Administration. TIP 63: medications for opioid use disorder. Accessed April 3, 2023. https:\/\/store.samhsa.gov\/sites\/default\/files\/pep21-02-01-002.pdf"},{"key":"zoi230392r36","unstructured":"Substance Abuse and Mental Health Services Administration. SAMHSA proposes update to federal rules to expand access to opioid use disorder treatment and help close gap in care. December 13, 2022. Accessed January 24, 2023. https:\/\/www.samhsa.gov\/newsroom\/press-announcements\/20221213\/update-federal-rules-expand-access-opioid-use-disorder-treatment"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2804672\/sue_2023_oi_230392_1683052039.94553.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T16:29:52Z","timestamp":1683736192000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2804672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,10]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.12718","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,10]]}}}